Protagenic Therapeutics Inc. (PTIX) Cash Flow Statement

Click line-items for a historical chart and %

Net loss
Depreciation and amortization
Amortization of purchased intangible assets	702K
Stock-based compensation expense
Loss on disposal of property, equipment and improvements	5K
Realized loss on sale of investment
Non-cash interest expense	0
Deferred income taxes	4K
Accounts receivable	-2.09M
Inventories
Prepaid expenses and other assets
Accounts payable and accrued expenses
Deferred revenue	-579K
Income taxes payable and prepaid income taxes
Net cash provided (used) by operating activities	1.51M
Purchase of equipment, inventory and intangible assets
Purchases of property, equipment and improvements	-556K
Capitalized software development costs
Proceeds from sales and maturities of investments	5.25M
Purchases of investments	-2.1M
Proceeds from sales of property, equipment and improvements
Net cash used by investing activities	1.31M
Net decrease in cash and cash equivalents
Cash and cash equivalents at beginning of period	7.55M
Cash and cash equivalents at end of period	10.39M
Other payable incurred for the purchase of assets

Entities mentioned with PTIX

View All Entities